Centre de Référence des Maladies Rénales Rares, Centre de Référence des Maladies Rares du Calcium et du Phosphore, Hôpital Femme Mère Enfant, Boulevard Pinel, 69677, Bron, France.
Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany.
Pediatr Nephrol. 2018 Sep;33(9):1565-1575. doi: 10.1007/s00467-018-3978-3. Epub 2018 Jun 5.
Mineral and bone disorders associated to chronic kidney disease (CKD-MBD) are a daily challenge for pediatric nephrologists, with a significant risk of long-term bone and vascular comorbidities.
This single-center study is a prospective transversal evaluation of pediatric CKD patients of our center, part of the European 4C study. In addition to clinical and biochemical data, vascular and bone evaluation was performed: 24-h blood pressure assessment, carotid intima-media thickness (cIMT), pulse wave velocity (PWV), and high-resolution peripheral quantitative computed tomography (HR-pQCT) at the ultra-distal tibia. Results are presented as median (range).
At a median age of 12.9 years (10.2-17.9), SDS height of - 1.0 (- 3.3-1.2) and estimated glomerular filtration rate (eGFR) of 33 mL/min/1.73m (11-72), 32 patients (8 girls) were evaluated. Median calcium, phosphate, parathyroid hormone (PTH), and 25 OHD3 levels were 2.44 mmol/L (2.24-2.78), 1.43 mmol/L (1.0-2.7), 80 pg/mL (9-359), and 70 nmol/L (32-116), respectively. Bivariate Spearman and backward multivariable analyses showed that calcium and bone trabecular thickness (Tb.Th), were positively associated with diastolic and mean arterial blood pressure (both for the 24 h, day and night assessment), whereas PTH and vitamin D did not predict blood pressure.
We show that the greater the serum levels of calcium, the greater the (diastolic and mean) blood pressure; moreover, the greater the Tb. Th, the greater the (diastolic and mean) blood pressure. The role of calcium supplements to explain such findings in early pediatric CKD can be discussed.
与慢性肾脏病(CKD)相关的矿物质和骨骼紊乱是儿科肾脏病医生面临的日常挑战,存在发生长期骨骼和血管合并症的重大风险。
本单中心研究是对我院参与的欧洲 4C 研究的部分儿科 CKD 患者进行的前瞻性横断面评估。除了临床和生化数据外,还进行了血管和骨骼评估:24 小时血压评估、颈动脉内膜中层厚度(cIMT)、脉搏波速度(PWV)和远段胫骨的高分辨率外周定量计算机断层扫描(HR-pQCT)。结果以中位数(范围)表示。
在中位年龄为 12.9 岁(10.2-17.9 岁)、身高标准差评分(SDS)为-1.0(-3.3-1.2)和估算肾小球滤过率(eGFR)为 33mL/min/1.73m(11-72)的情况下,评估了 32 名患者(8 名女孩)。钙、磷、甲状旁腺激素(PTH)和 25 羟维生素 D3 的中位数水平分别为 2.44mmol/L(2.24-2.78)、1.43mmol/L(1.0-2.7)、80pg/mL(9-359)和 70nmol/L(32-116)。双变量 Spearman 和向后多变量分析表明,钙和骨小梁厚度(Tb.Th)与舒张压和平均动脉血压呈正相关(24 小时、白天和夜间评估均如此),而 PTH 和维生素 D 不预测血压。
我们表明,血清钙水平越高,血压越高(包括舒张压和平均动脉压);此外,Tb.Th 越高,血压越高(包括舒张压和平均动脉压)。可以讨论钙补充剂在早期儿科 CKD 中解释这些发现的作用。